[go: up one dir, main page]

WO2003061746A1 - Inhalateur - Google Patents

Inhalateur Download PDF

Info

Publication number
WO2003061746A1
WO2003061746A1 PCT/JP2003/000712 JP0300712W WO03061746A1 WO 2003061746 A1 WO2003061746 A1 WO 2003061746A1 JP 0300712 W JP0300712 W JP 0300712W WO 03061746 A1 WO03061746 A1 WO 03061746A1
Authority
WO
WIPO (PCT)
Prior art keywords
fine water
water droplet
inhaler
water
ultrasonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2003/000712
Other languages
English (en)
Japanese (ja)
Inventor
Takashi Nakamura
Kunji Sakamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panasonic Ecology Systems Co Ltd
Original Assignee
Matsushita Ecology Systems Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matsushita Ecology Systems Co Ltd filed Critical Matsushita Ecology Systems Co Ltd
Priority to JP2003561686A priority Critical patent/JP4675566B2/ja
Publication of WO2003061746A1 publication Critical patent/WO2003061746A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0085—Inhalators using ultrasonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/02—Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0057—Pumps therefor
    • A61M16/0066—Blowers or centrifugal pumps

Definitions

  • the present invention relates to an inhaler used for respiratory assistance or therapy.
  • a diffuser-type humidifier a spray / atomization type ultrasonic nebulizer
  • a jet nebulizer using water droplet splitting by the bench lily effect. Both have a humidifying function, and can be heated and inhaled by using a heater in combination. In addition, it is connected to oxygen at a concentration of about 40% by volume and used for oxygen therapy.
  • nebulizers are products that only consider the size of droplets (water droplets), that is, the particle size.
  • a positive ion refers to a case where the ratio of the negative ion (n—) to the positive ion (n +) (ion ratio; n—Zn +) is 0.5 or less. If the ion ratio is 2 or more, it is called a negative ion. When the ion ratio is between 0.5 and 2, it is considered that positive ions and negative ions are almost balanced.
  • AL-Rhose is a condition in which the pH of blood has risen to the AL-rh side. Atidosis is an acidified state.
  • the normal pH value of blood is 7.35 to 7.45, which is weakly alkaline.
  • small air ions have a physiological activity.
  • the performance of inhalers has not been enhanced from the viewpoint of small air ions.
  • the HD 101 is provided with a water tank 102, a diffuser tube 103, a supply tube 104 communicating with the diffuser tube 103, and a suction port 105. Consists of By providing the air diffuser tube 103, the supply air is humidified. The supply air is supplied from the supply port 106 of the HD 101, passes through the supply pipe 104, and is sent to the diffuser pipe 103 in the water tank 102. Since the air diffuser tube 103 is porous, the air passing therethrough tends to be fine bubbles. Air sent to diffuser 103 is fine
  • JN 10 using the bench lily effect 7 has a water tank 102, a supply pipe 104, and a suction pipe 108.
  • the supply pipe 104 has a supply port 106 and a nozzle 109 at the tip of the supply pipe 104, and a suction pipe 108 near the nozzle 109 at the tip of the supply pipe 104. It has a structure with an outlet 110.
  • the air for inhalation or high concentration oxygen for inhalation sent from the supply port 106 to the supply pipe 104 is blown out from the nozzle 109 at the tip of the supply pipe 104.
  • the humidifying water for humidification in the water tank 102 or the medical solution for treatment is sucked from the suction pipe 108 and sprayed from the outlet 110.
  • the supply air or high-concentration oxygen requires high-speed airflow at the nozzle 109, and is used under pressure.
  • the sprayed humidified water or chemical liquid becomes sprayed water droplets, and is mixed with the suction air or the high-concentration oxygen for suction sent from the supply port 106 to the supply pipe 104 in the spray mixing section 111. In addition, it is mixed with the indoor air sent from the indoor air suction port 112, and adjusted to an appropriate oxygen concentration, humidity, or an appropriate drug concentration. Next, it is sent to the inlet 105 for treatment or respiratory support. ⁇ Since there is no special drop separation mechanism, it is supplied with water droplets of various sizes. Although not shown, the heater is appropriately heated and supplied according to the usage conditions. In FIG. 8, the dotted arrow indicates the flow direction of water or the chemical solution. The dashed-dotted arrow indicates the flow direction of the indoor air.
  • the two-dot chain arrow indicates the flow direction of the supply air or high concentration oxygen.
  • the solid arrows indicate the flow direction of the mixed air and the conditioned air adjusted to the appropriate oxygen concentration, humidity, or appropriate drug concentration.
  • High-concentration oxygen means that the oxygen concentration is about 40% by volume. Or more. The case where the oxygen concentration is about 98% by volume to 100% by volume is also included.
  • Supply air may be used as room air.
  • the air ion content was measured for the HD and JN described above and another conventional inhaler, an ultrasonic nebulizer.
  • the method of measuring the positive ion amount (n +) and negative ion amount (n—) at the inlet of each type of inhaler is as follows, and the measurement results are shown in Table 2.
  • the comparison is indoor air.
  • HD See Fig. 7: Blow oxygen at a flow rate of 5, 10, and 15 (1 / in) into purified water heated by a heater at a concentration of 50% by volume. Then, each ion amount is measured by an ion tester at a position 10 cm away from the inlet.
  • JN (see Fig. 8): Flow oxygen adjusted to a concentration of 35% by volume at flow rates of 5, 10 and 15 (lZmin). Then, the amount of each ion is measured in the same manner as for HD while aspirating the purified water in the container by the bench lily effect.
  • 4-Ultrasonic nebulizer Put purified water into the container on the ultrasonic vibrator and flow oxygen adjusted to a concentration of 35% by volume at flow rates of 5, 10 and 15 (IZmin). Then, the purified water is evaporated, and the amount of each ion is measured in the same manner as for HD.
  • the ion tester used for the measurement has a mobility of 0.4 cm 2 ZV ⁇ s or more.
  • Table 2 shows the results.
  • the steam humidifier heated by a heater or the like hardly generates air ions. In other words, there is almost no air ion function.
  • JN and ultrasonic nebulizers are considered to be
  • the amount of gas ions generated is very large. However, the ion ratio is about 0.5, which is considered to be almost positive from the viewpoint of air ions.
  • Table 2 Air ions in the room and various inhalers
  • An object of the present invention is to provide a compact inhaler capable of suppressing generation of positive ions, generating a large amount of negative ions as compared with positive ions, and capable of separating water droplets with high performance. .
  • the nature of the inhaler product requires compactness.
  • using a water droplet separation mechanism that separates water droplets to suppress the generation of positive ions and generates a larger amount of negative ions than positive ions increases the overall size of the device, making it difficult to achieve compactness. It also has the problem of being Disclosure of the invention
  • an inhaler including a negative ion generating and humidifying means for generating and humidifying negative ions by water splitting.
  • An inhaler comprising: a water droplet separating means.
  • a main body a fine water droplet generator provided in the main body, a separator provided downstream of the fine water droplet generator, and a suction port downstream of the separator.
  • the generating unit includes a water tank provided at a lower part of the main body, an ultrasonic vibrator provided at a lower part of the water tank, and an ultrasonic circuit for driving the ultrasonic vibrator, wherein the ultrasonic vibrator and the ultrasonic vibrator are provided.
  • a sound wave circuit generates fine water droplets.
  • the inhaler includes splitting / separating means, the reseparating / separating means includes a wire mesh and wire mesh rotating means for rotating the wire mesh, and introduces high humidity air containing a large amount of negative ions into the inlet.
  • FIG. 1 is a sectional view of an inhaler according to Embodiment 1 of the present invention.
  • FIG. 2 is a plan view of a wire mesh of the inhaler according to the first embodiment of the present invention.
  • FIG. 3 is a diagram showing a state of water droplet separation of the inhaler according to the first embodiment of the present invention.
  • FIG. 4 is a cross-sectional view of Embodiment 1 of the present invention, in which a tube is provided in a wire mesh of the inhaler.
  • FIG. 5 is a sectional view of the inhaler according to the second embodiment of the present invention.
  • FIG. 6 is a cross-sectional view of an inhaler according to Embodiment 3 of the present invention.
  • FIG. 7 is a cross-sectional view showing a conventional inhaler HD.
  • FIG. 8 is a cross-sectional view showing a conventional inhaler JN.
  • BEST MODE FOR CARRYING OUT THE INVENTION In examining the biologically active effects of negative ions on living organisms due to water splitting, first consider whether water-derived negative ions may enhance the biological activity of living organisms. Preliminary test was conducted. The preliminary test conditions are shown below. As a model for atopic dermatitis, mice develop chronic contact dermatitis in the ears of mice. Next, we exposed to negative ions derived from water and generated by water splitting, and examined the possibility that negative ions could enhance the physiological activity.
  • the comparative tests were performed on a group exposed to normal air (hereinafter referred to as a control group) and a group exposed to negative ions generated by corona discharge (hereinafter referred to as an electric ion group).
  • the group exposed to negative ions derived from water and generated by water splitting is hereinafter referred to as the true group.
  • Temperature and humidity 22 ° C ⁇ 1.5.
  • C, 55% ⁇ 10% RH, average negative ion amount are: Masaki group: 1,200,000 Zcc, Electric ion group: 3 0, 0 000 Zee (However, only in this group, the ozone concentration was detected at 310 ppb), and the control group: 0 pcs / cc.
  • Table 3 Changes in earlobe thickness (unit: mm) As shown in Table 3, the Masaki group (the group exposed to negative ions derived from water) showed good results with a significant difference from the control group. In other words, it is suggested that negative ions from water may enhance the biological activity of living organisms. In other words, it has a beneficial effect on the living body.
  • the electric ion group group exposed to negative ions generated by corona discharge
  • the electric ion group is worse than the control group, which may be due to the effect of ozone.
  • the biologically active effect of the living body is different between negative ions originating from water and due to water splitting and negative ions generated by a discharge phenomenon (electrical type) such as corona discharge. Seems to be.
  • neurosurgical patients with high lactate levels in arterial blood of 1.5 (mmol / l) or more were randomly selected from 20 patients and divided into two groups.
  • the values measured during the experiment were as follows: the amount of negative ions: about 2,500 Zee, the amount of positive ions: about 400 / cc, and the ion ratio (n ⁇ / n +) was 6.2. It was five. The ratio of the amount of negative ions is very high.
  • This device is referred to as the “negative device”.
  • the amount of negative ions about 200,000 Zee
  • the amount of positive ions about 100,000 pieces / cc
  • the ion ratio (n-/ n +) is 0.2. there were.
  • the ratio of the amount of positive ions was very high.
  • This device is referred to as the “primary device”. After adjusting the oxygen concentration to 40% by volume, pour it into both devices, and inhale through the inlet in the following procedure.
  • One group (10 people) inhales the first 4 hours from the negative device and the remaining 4 hours from the positive device. Conversely, the other group (10 people) inhale the first 4 hours from the positive device and the remaining 4 hours from the negative device.
  • Table 4 shows the results measured every hour.
  • Negative device 1 2. 7 8 Negative device 1 2. 8 6
  • Negative device 2 2. 7 3 Negative device 2 2. 9 5
  • Negative device 4 2. 2 9 Negative device 4 2-4 9
  • Main unit .1 2.5 7
  • Main unit 1 2.03
  • Main unit 2 2. 7 3 Main unit 2 1.7 .0
  • Main unit 3 2.8.2 Main unit 3 1.6
  • Negative ions derived from water accelerate the ATP generation reaction in vivo, lowering the concentration of oxygen to be inhaled, shortening the oxygen inhalation time, or reducing the lactate concentration in arterial blood even with normal air be able to. In other words, oxygen treatment or respiratory support can be performed more safely.
  • the water splitting or water drop splitting referred to in the present invention does not cover a steam-type humidifying inhaler heated by heat or the like.
  • the mechanical force expressed by water splitting or droplet splitting is applied to water, It refers to a method of ion dissociating water by applying high energy.
  • the mechanical force is a force that uses the vibration energy of an ultrasonic vibrator, a force that uses the bench lily effect like JN, a force that uses injection such as a nozzle type, a collision, etc., a rotating disk type, This is a force that uses injection, collision, and centrifugal force, such as a set of impellers and a centrifugal type.
  • the main body 1 of the inhaler is equipped with an ultrasonic vibrator 2 at the bottom and a water tank 102 containing water or a chemical solution, and an atomizing section 3 provided at the top of the water tank.
  • a blower 4 for blowing air to the atomizing section 3, a partition plate 5 having an opening 6 provided above the atomizing section 3, a wire mesh 7 provided above the partition plate 5, and a wire mesh.
  • a wire mesh rotation motor 8 for rotating the motor.
  • a suction port 105 is provided at the top of the main body 1 of the inhaler.
  • the water or the chemical solution in the water tank 102 is sprayed or atomized by the ultrasonic vibrator 2 provided at the bottom of the water tank 102.
  • the sprayed or atomized water or fine water droplets of the chemical solution are sent to the atomizing section 3 by the air blower 4 to be mixed with fine water droplets and sent to the partition plate 5.
  • the relatively large water droplets are separated and removed by the baffle plate action and the inertia separation action of the partition plate 5, and then sent to the wire mesh 7 from the opening 6 of the partition plate.
  • the wire mesh 7 is rotated by a wire mesh rotating motor 8.
  • the water in the air mixed with fine water droplets from which relatively large water droplets have been removed by the partition plate 5 or the water droplets of the chemical solution are Causes water droplets to re-divide and re-aggregate. Then, the fine water droplets are separated, and the fine water droplet mixed air is converted into a smaller ultra-fine water droplet mixed air.
  • the ion balance ratio between positive ions and negative ions which are generated in approximately equal amounts during water splitting, is disrupted.
  • the ion balance ratio of the negative ions at the inlet 105 is more than twice as large as the positive ions.
  • the ultra-fine water-droplet mixed air containing high amount of negative ions and having high humidity and biological activity is sent to the inlet 105 and used for respiratory assistance or treatment.
  • the partition plate 5 performs relatively large water droplet separation, but in combination with the fine water droplet separation by the rotation of the wire mesh 7, the water droplet separation is performed to such an extent that the ion balance is disturbed so that the negative ions become more than twice the positive ions. If possible. For this reason, whether the partition plate 5 should be one-stage, two-stage, or two-stage or more, or not used should be appropriately designed based on the positive / negative ion ratio to be obtained and the air volume. Just decide. Next, the device specifications are described below.
  • FIG. 2 is a plan view of the wire mesh 7. Oxygen adjusted to an oxygen concentration of 40% by volume with an oxygen concentration controller is introduced into the device at each flow rate (1 / min) of 5, 10, and 15.
  • Table 5 shows the results of measurements with an ion tester and a thermo-hygrometer at a position 10 cm from the inlet.
  • Table 5 Negative ion positive ion amount, temperature and humidity
  • the supply of high-concentration oxygen to the inhaler is performed by connecting to oxygen with an oxygen concentration of 40% by volume adjusted by an oxygen concentration controller.
  • an oxygen cylinder that supplies 98% to 100% pure oxygen
  • an oxygen generator that generates oxygen by chemical reaction or water electrolysis
  • the device is appropriately selected and used depending on the use conditions such as the oxygen concentration to be administered and the place of use.
  • An appropriately selected high-concentration oxygen supply device is connected to an inhaler that generates negative ions from water and water splitting, and is used for respiratory support or treatment.
  • an inhaler that generates negative ions due to water splitting due to water splitting may be incorporated into a device that supplies high-concentration oxygen.
  • Figure 3 shows the state of water droplet splitting and water droplet aggregation at the rotating wire mesh.
  • Fig. 1 shows the state of water droplet splitting and water droplet aggregation.
  • Fig. 3 is a schematic diagram, and it may not be possible to accurately represent the situation visually confirmed.
  • the material atomized by the ultrasonic vibrator is sent from the upper inlet 9 and passed through the wire mesh 7 rotating through the shaft 10 by the wire mesh rotating motor 8.
  • the rotation of the wire mesh 7 causes the re-splitting and aggregation of the atomized fine water droplets and the separation of the fine water droplets, resulting in ultra-fine water droplets.
  • the wire mesh 7 In the upper region 11 of the wire mesh 7, into which fine water droplets due to atomization flow, there are countless fine water droplets, which are opaque due to atomization and fine water droplets.
  • a cyclone separator 15 is provided above the atomization section 3 in the body 1 of the inhaler.
  • the air mixed with fine water droplets including the fine water droplets atomized by the ultrasonic vibrator 2 and the blowing device 4 is supplied to the cyclone separator. Sent on evening 15.
  • the air mixed with fine water droplets is sent from the cyclone inlet 16 into the cyclone separator 15 and forms a swirling flow.
  • the fine water droplets are centrifuged, the ion balance between the positive ions and the negative ions is broken, and the air becomes ultra-fine water-droplet mixed air containing a large amount of negative ions. Sent to In this way, it is used for respiratory assistance or treatment.
  • the air was blown to the atomizing section 3 by the blower 4 using a swirling flow, and the wind speed was set to 1.0 mZ sec and 2.5 m / sec.
  • Table 6 shows the experimental results.
  • the state of water droplets in the atomization unit 3 is that the central atomized particle diameter is about 3 microns in the case of an ultrasonic oscillator for atomization. Cloudy water droplets are also seen from the outlet 17 of the cyclone separator 15 in a cloudy state from the atomization section 3 to the inside of the cyclone separator 15.
  • a water column of about 5 cm is formed at the center of the swirling flow of the atomizing section 3 and becomes steamy from there. At the exit 17 of the cyclone separator, the outlet 17 was no longer steamy.
  • the experimental results with the ultrasonic oscillators at 100 kHz and 500 kHz also yielded almost the same ion ratio.
  • the inhaler containing a large amount of negative ions aimed at by the present invention can be obtained by adjusting the ultrasonic oscillation frequency range of the ultrasonic oscillator to 100 kHz to 500 kHz.
  • Table 6 Comparison of ultrasonic nebulizer and cyclone separator
  • a wire mesh 7 and a wire mesh rotating motor 8 for rotating the wire mesh are provided downstream of the spray mixing section 1 11 in the main body 107 of the inhaler.
  • the mixed air of fine water droplets including the fine water droplets mixed in the spray mixing section 1 1 1 1 is caused by the rotation of the wire mesh 7 to re-divide the atomized fine water droplets and separate them into fine water droplets.
  • Ultra-fine water droplets As a result, relatively large fine water droplets that are positively charged are separated and removed, and the ion balance between the positive ions and the negative ions is disrupted, generating a large amount of negative ions. Then, it is sent to the inlet 105 and used for respiratory assistance or treatment. In this way, it is possible to provide a small inhaler that effectively generates negative ions.
  • the present invention breaks the ion balance between positive ions and negative ions, Provide a small inhaler that generates a larger amount of negative ions than ions. As a result, the level of lactic acid, a fatigue substance, is significantly reduced, and the biological activity of the living body can be improved.
  • the present invention provides an inhaler that connects high-concentration oxygen to supply high-concentration oxygen with a large amount of negative ions with a negative ion and positive ion imbalance. Small size that enhances the physiological activity of the living body and achieves an oxygen inhalation effect with a short period of high-concentration oxygen inhalation or a lower concentration of oxygen, which allows safer oxygen therapy and oxygen inhalation Provide an inhaler.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electrotherapy Devices (AREA)

Abstract

Petit inhalateur qui comporte un vibrateur ultrasonore (2), un réservoir à eau (102), une partie d'atomisation (3), une soufflante (4) et un filet métallique (7) installé au-dessus de la partie d'atomisation (3). Lorsque le filet métallique (7) est mis en rotation, les gouttelettes d'eau atomisées produites par le vibrateur ultrasonore (2) sont divisées une nouvelle fois et séparées de manière à porter le rapport entre la quantité d'ions négatifs et la quantité d'ions positifs à 2 ou plus, une quantité importante d'ions négatifs issus de l'eau pouvant être produite pour accélérer l'efficacité biologique.
PCT/JP2003/000712 2002-01-25 2003-01-27 Inhalateur Ceased WO2003061746A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003561686A JP4675566B2 (ja) 2002-01-25 2003-01-27 吸入器

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002-16572 2002-01-25
JP2002016572 2002-01-25

Publications (1)

Publication Number Publication Date
WO2003061746A1 true WO2003061746A1 (fr) 2003-07-31

Family

ID=27606135

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2003/000712 Ceased WO2003061746A1 (fr) 2002-01-25 2003-01-27 Inhalateur

Country Status (2)

Country Link
JP (1) JP4675566B2 (fr)
WO (1) WO2003061746A1 (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006087446A (ja) * 2004-09-21 2006-04-06 Sharp Corp ネブライザー、ネブライザーを搭載した環境調整装置及びネブライザーの殺菌方法
JP2008050249A (ja) * 2006-05-19 2008-03-06 Air Products & Chemicals Inc ルイス気体／液体系を製造しその系からルイス気体を回収する接触法
JP2010519973A (ja) * 2007-02-28 2010-06-10 マイクロドース セラピューテクス，インコーポレイテッド 吸入器
GB2469876A (en) * 2009-05-01 2010-11-03 Yuri Rapoport Inhalation apparatus for recreational, medical, or homeopathic purposes
CN105079927A (zh) * 2014-05-15 2015-11-25 郎彦宇 睡眠呼吸机
CN106156806A (zh) * 2015-04-01 2016-11-23 冠捷投资有限公司 显示器的防止疲劳的方法
WO2017179569A1 (fr) * 2016-04-13 2017-10-19 株式会社メトラン Humidificateur et dispositif d'assistance respiratoire
JP2019507487A (ja) * 2015-12-03 2019-03-14 杭州伊聖泰医療科技有限公司Ｈａｎｇｚｈｏｕ Ｅｓｔａｉ Ｍｅｄｉｃａｌ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏ．， Ｌｔｄ 水分子を携帯する高圧気流の衝突面と衝突する空気マイナスイオン発生装置
CN110772694A (zh) * 2019-12-06 2020-02-11 常州市第一人民医院 一种具有湿化功能的呼吸装置
IT202000028811A1 (it) * 2020-11-27 2022-05-27 Quantimek Di Bertoncello Claudio Dispositivo umidificatore di fluido gassoso secco
KR102762439B1 (ko) * 2023-10-25 2025-02-04 주식회사 세인메디 간소화된 구조를 가지는 의료용 가습장치

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2565028Y2 (ja) * 1991-07-25 1998-03-11 株式会社荻原製作所 ミスト発生器
JP2000225189A (ja) * 1999-02-06 2000-08-15 Icc Kk 超音波振動力利用珊瑚セラミックの機能生理活性負イオン空気製造方法
JP2001198219A (ja) * 2000-01-21 2001-07-24 Icc Kk 水の気体イオン化における小イオン空気の分離装置と方法
JP2001233761A (ja) * 2000-02-18 2001-08-28 Yasunobu Yoshida 負イオン発生機による医薬品等の体内投与方法及び装置
JP2001321625A (ja) * 2000-05-19 2001-11-20 Matsushita Seiko Co Ltd 負イオン発生装置
WO2003020348A1 (fr) * 2001-08-29 2003-03-13 Bio Media Co., Ltd. Dispositif d'aspiration
JP5058755B2 (ja) * 2007-11-06 2012-10-24 リコーエレメックス株式会社 液吐出不良検出装置、およびインクジェット記録装置

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2565028Y2 (ja) * 1991-07-25 1998-03-11 株式会社荻原製作所 ミスト発生器
JP2000225189A (ja) * 1999-02-06 2000-08-15 Icc Kk 超音波振動力利用珊瑚セラミックの機能生理活性負イオン空気製造方法
JP2001198219A (ja) * 2000-01-21 2001-07-24 Icc Kk 水の気体イオン化における小イオン空気の分離装置と方法
JP2001233761A (ja) * 2000-02-18 2001-08-28 Yasunobu Yoshida 負イオン発生機による医薬品等の体内投与方法及び装置
JP2001321625A (ja) * 2000-05-19 2001-11-20 Matsushita Seiko Co Ltd 負イオン発生装置
WO2003020348A1 (fr) * 2001-08-29 2003-03-13 Bio Media Co., Ltd. Dispositif d'aspiration
JP5058755B2 (ja) * 2007-11-06 2012-10-24 リコーエレメックス株式会社 液吐出不良検出装置、およびインクジェット記録装置

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006087446A (ja) * 2004-09-21 2006-04-06 Sharp Corp ネブライザー、ネブライザーを搭載した環境調整装置及びネブライザーの殺菌方法
JP2008050249A (ja) * 2006-05-19 2008-03-06 Air Products & Chemicals Inc ルイス気体／液体系を製造しその系からルイス気体を回収する接触法
JP2010519973A (ja) * 2007-02-28 2010-06-10 マイクロドース セラピューテクス，インコーポレイテッド 吸入器
GB2469876A (en) * 2009-05-01 2010-11-03 Yuri Rapoport Inhalation apparatus for recreational, medical, or homeopathic purposes
CN105079927A (zh) * 2014-05-15 2015-11-25 郎彦宇 睡眠呼吸机
CN106156806A (zh) * 2015-04-01 2016-11-23 冠捷投资有限公司 显示器的防止疲劳的方法
JP2019507487A (ja) * 2015-12-03 2019-03-14 杭州伊聖泰医療科技有限公司Ｈａｎｇｚｈｏｕ Ｅｓｔａｉ Ｍｅｄｉｃａｌ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏ．， Ｌｔｄ 水分子を携帯する高圧気流の衝突面と衝突する空気マイナスイオン発生装置
JPWO2017179569A1 (ja) * 2016-04-13 2019-02-21 株式会社メトラン 加湿器、呼吸補助装置
CN109069785A (zh) * 2016-04-13 2018-12-21 株式会社美全 加湿器、呼吸辅助装置
WO2017179569A1 (fr) * 2016-04-13 2017-10-19 株式会社メトラン Humidificateur et dispositif d'assistance respiratoire
CN109069785B (zh) * 2016-04-13 2021-04-02 株式会社美全 加湿器、呼吸辅助装置
US11305089B2 (en) 2016-04-13 2022-04-19 Metran Co., Ltd. Humidifier and respiratory assistance device
CN110772694A (zh) * 2019-12-06 2020-02-11 常州市第一人民医院 一种具有湿化功能的呼吸装置
CN110772694B (zh) * 2019-12-06 2020-06-05 常州市第一人民医院 一种具有湿化功能的呼吸装置
IT202000028811A1 (it) * 2020-11-27 2022-05-27 Quantimek Di Bertoncello Claudio Dispositivo umidificatore di fluido gassoso secco
WO2022112983A3 (fr) * 2020-11-27 2022-07-07 Quantimek Di Bertoncello Claudio Dispositif humidificateur de fluide gazeux sec
KR102762439B1 (ko) * 2023-10-25 2025-02-04 주식회사 세인메디 간소화된 구조를 가지는 의료용 가습장치

Also Published As

Publication number Publication date
JPWO2003061746A1 (ja) 2005-05-19
JP4675566B2 (ja) 2011-04-27

Similar Documents

Publication Publication Date Title
WO2003061746A1 (fr) Inhalateur
CN102159271A (zh) 气雾吸入器
CN109432556B (zh) 一种智能儿科用药物雾化器及其使用方法
JP2018031070A (ja) ガス発生器
CN212348674U (zh) 超声波盐气溶胶发生器
CN203507247U (zh) 机械通气专用雾化器
CN113768910A (zh) 包含富马酸福莫特罗吸入溶液的药物组件及其用途
CN212593378U (zh) 一种高性能震动微网孔雾化器
CN106178398A (zh) 一种健身器材及其制氧雾化系统
JPH01185267A (ja) 新吸入器
CN110975077A (zh) 一种医用雾化器
CN107029324A (zh) 一种超声波医用雾化器
CN222942769U (zh) 一种双仓雾化装置
CN221888919U (zh) 儿童哮喘雾化器
CN219148837U (zh) 一种即雾化即吸入式雾化给药装置
CN219185371U (zh) 一种适用于多种场景的雾化装置
CN110935085A (zh) 一种医用雾化器
CN217091689U (zh) 一种可自动切换药液的雾化器
CN116920229A (zh) 一种老年呼吸患者雾化装置
CN116747389A (zh) 一种用于药物超声雾化治疗的一次性积水杯
CN109954189B (zh) 一种多功能雾化器
US20220062569A1 (en) Ultrasonic diffuser apparatus and related system and method of administering water-compatible nanoemulsions
CN209187788U (zh) 一种基于气体喷管的医用超声雾化喷头
CN219127785U (zh) 一种超声雾化器
CN117427243A (zh) 一种即雾化即吸入式雾化给药装置

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2003561686

Country of ref document: JP

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1)EPC(EPO F1205A DATED 041004)

122 Ep: pct application non-entry in european phase